ETBI

Eastgate Biotech (CE) Stock Price

0.006
0.00 (0.0%)
0.006
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Eastgate Biotech Corporation (CE) ETBI OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.006 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.006 0.006
Bid Price Ask Price Spread News
0.0071 0.0081 0.001 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.006 USD

Eastgate Biotech (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.35M 1.06B - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Eastgate Biotech (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ETBI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0020.0060.0020.00622,0000.004200.0%
1 Month0.0020.030.0020.003949165,4180.004200.0%
3 Months0.0050.030.00150.004103979,9270.00120.0%
6 Months0.00130.030.00010.0031829123,0530.0047361.54%
1 Year0.01160.030.00010.0077671572,380-0.0056-48.28%
3 Years0.00120.030.00010.00485231,868,2180.0048400.0%
5 Years0.0140.0450.00010.00574462,527,945-0.008-57.14%

Eastgate Biotech (CE) Description

EastGate Biotech Corp. is a biotech company concentrating on altering the delivery ways for well-known drugs, currently administered only by injections, to non-invasive (oral or sublingual) routes. We are developing a technology platform for enhanced drug delivery designed to improve compliance and increase health benefits to fit today’s health-conscious lifestyles. At the present time our technology focuses on the delivery of insulin via a liquid insulin mouth solution based on a proprietary/Trade Secret composition for the treatment of Type 2 diabetes patients and Alzheimer’s disease. We believe that our technology may also be applicable to the delivery of other active pharmaceutical ingredients. We may also develop other novel formulations of pharmaceutical and natural products. The company has identified several biologically active existing molecules that address unmet needs of patients, especially those with ever-growing chronic conditions.


Your Recent History
USOTC
ETBI
Eastgate B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.